Interleukin-12-induced interferon-γ production by human peripheral blood T cells is regulated by mammalian target of rapamycin (mTOR)

被引:49
作者
Kusaba, H [1 ]
Ghosh, P [1 ]
Derin, R [1 ]
Buchholz, M [1 ]
Sasaki, C [1 ]
Madara, K [1 ]
Longo, DL [1 ]
机构
[1] NIA, Lymphocyte Cell Biol Unit, Immunol Lab, Gerontol Res Ctr,NIH, Baltimore, MD 21224 USA
关键词
D O I
10.1074/jbc.M405204200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Depending on the type of external signals, T cells can initiate multiple intracellular signaling pathways that can be broadly classified into two groups based on their sensitivity to the immunosuppressive drug cyclosporin A (CsA). Interleukin (IL)-12-mediated interferon (IFN)-gamma production by activated T cells has been shown to be CsA-insensitive. In this report, we demonstrate that the IL-12-induced CsA-resistant pathway of IFN-gamma production is sensitive to rapamycin. Rapamycin treatment resulted in the aberrant recruitment of Stat3, Stat4, and phospho-c-Jun to the genomic promoter region resulting in decreased IFN-gamma transcription. IL-12-induced phosphorylation of Stat3 on Ser-727 was affected by rapamycin, which may be due to the effect of rapamycin on the IL-12-induced interaction between mammalian target of rapamycin ( mTOR) and Stat3. In accordance with this, reduction in the mTOR protein level by small interfering RNA resulted in suppression of Stat3 phosphorylation and decreased production of IFN-gamma after IL-12 stimulation. These results suggest that mTOR may play a major role in IL-12-induced IFN-gamma production by activated T cells.
引用
收藏
页码:1037 / 1043
页数:7
相关论文
共 38 条
[1]  
Barbulescu K, 1998, J IMMUNOL, V160, P3642
[2]   EVIDENCE THAT RAPAMYCIN INHIBITS INTERLEUKIN-INDUCED PROLIFERATION OF ACTIVATED T-LYMPHOCYTES [J].
BERTAGNOLLI, MM ;
YANG, L ;
HERRMANN, SH ;
KIRKMAN, RL .
TRANSPLANTATION, 1994, 58 (10) :1091-1096
[3]   2 DISTINCT SIGNAL TRANSMISSION PATHWAYS IN LYMPHOCYTES-T ARE INHIBITED BY COMPLEXES FORMED BETWEEN AN IMMUNOPHILIN AND EITHER FK506 OR RAPAMYCIN [J].
BIERER, BE ;
MATTILA, PS ;
STANDAERT, RF ;
HERZENBERG, LA ;
BURAKOFF, SJ ;
CRABTREE, G ;
SCHREIBER, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9231-9235
[4]   Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: Tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide [J].
Brazelton, TR ;
Morris, RE .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (05) :710-720
[5]   A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX [J].
BROWN, EJ ;
ALBERS, MW ;
SHIN, TB ;
ICHIKAWA, K ;
KEITH, CT ;
LANE, WS ;
SCHREIBER, SL .
NATURE, 1994, 369 (6483) :756-758
[6]  
CHAN SH, 1992, J IMMUNOL, V148, P92
[7]   INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS [J].
CHAN, SH ;
PERUSSIA, B ;
GUPTA, JW ;
KOBAYASHI, M ;
POSPISIL, M ;
YOUNG, HW ;
WOLF, SF ;
YOUNG, D ;
CLARK, SC ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :869-879
[8]   Generic signals and specific outcomes:: Signaling through Ca2+, calcineurin, and NF-AT [J].
Crabtree, GR .
CELL, 1999, 96 (05) :611-614
[9]   Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway [J].
Ghosh, P ;
Buchholz, MA ;
Yano, S ;
Taub, D ;
Longo, DL .
BLOOD, 2002, 99 (12) :4517-4524
[10]  
Gollob JA, 1999, J IMMUNOL, V162, P4472